4-(4-(Hydroxymethyl)phenoxy)-N-(5-methylthiazol-2-yl)butanamide

ID: ALA4561296

PubChem CID: 155543343

Max Phase: Preclinical

Molecular Formula: C15H18N2O3S

Molecular Weight: 306.39

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(NC(=O)CCCOc2ccc(CO)cc2)s1

Standard InChI:  InChI=1S/C15H18N2O3S/c1-11-9-16-15(21-11)17-14(19)3-2-8-20-13-6-4-12(10-18)5-7-13/h4-7,9,18H,2-3,8,10H2,1H3,(H,16,17,19)

Standard InChI Key:  KHQUOOYFOSJPFQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   19.0994   -4.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0983   -5.1325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8063   -5.5414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5160   -5.1320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5131   -4.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8045   -3.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3916   -3.9045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6840   -4.3133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9762   -3.9048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2686   -4.3136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5608   -3.9052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8531   -4.3139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5606   -3.0880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1453   -3.9055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0586   -3.0944    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.2592   -2.9247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8508   -3.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3978   -4.2396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9267   -2.1783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2243   -5.5395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2256   -6.3567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
 16 19  1  0
  4 20  1  0
 20 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4561296

    ---

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tat Human immunodeficiency virus type 1 Tat protein (1183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.39Molecular Weight (Monoisotopic): 306.1038AlogP: 2.74#Rotatable Bonds: 7
Polar Surface Area: 71.45Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.08CX Basic pKa: 0.52CX LogP: 2.48CX LogD: 2.40
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.77Np Likeness Score: -1.52

References

1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE..  (2019)  Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models.,  62  (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462]

Source